medigraphic.com
ISSN 0016-3813 (Print)

2009, Number 2

<< Back Next >>

Gac Med Mex 2009; 145 (2)

Tipos histológicos y métodos diagnósticos en cáncer pulmonar en un centro hospitalario de tercer nivel

Gurrola-Díaz CM, González-Santiago AE, Troyo-Sanromán R, Mendoza-Topete LA

Language: Spanish
References: 25
Page: 97-101
PDF size: 76.62 Kb.


ABSTRACT

Objective: To describe the histological frequencies, diagnostic methods, gender and age of lung cancer patients in a third level care hospital in western Mexico.
Methods: A retrospective and descriptive study (2002 to 2005) was undertaken. From all reviewed cases, 242 patients had a diagnosis compatible with lung cancer. We analyzed the histological type, gender, age group, and diagnostic method.
Results: The histological type frequencies of lung cancer were as follows: 63.6% adenocarcinoma, 19.0% squamous cell carcinoma, 15.2% small cell carcinoma, and 2.2% large-cell carcinoma. Among these patients, a male-female ratio of 2:1 with a mean age of 63 years was found. Regarding the diagnostic methods followed, the most common included: transthoracic needle aspiration, bronchial biopsy, and bronchial washing.
Conclusions: Adenocarcinoma was the most frequent histological type in the sample studied, an association between female gender and risk of developing adenocarcinoma was detected.


REFERENCES

  1. Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med 2005;172:523-529.

  2. Lazcano-Ponce EC, Tovar-Guzmán V, Meneses-González F, Rascón-Pacheco RA, Hernández-Ávila M. Trends of lung cancer mortality in Mexico. Arch Med Res 1997;28:565-570.

  3. Medina-Morales F, Salazar-Flores M. Frecuencia y patrón cambiante del cáncer pulmonar en México. Salud Publica Mex 2000;42:333-336.

  4. Medina-Morales F, Salazar-Flores M, García-Sancho MC, Franco FM. Epidemiología descriptiva del cáncer pulmonar en el Instituto Nacional de Enfermedades Respiratorias, México, 1997-2000. Rev Inst Nal Enf Resp Mex 2002;15:149-152.

  5. Rivera-Rosales RM, Salazar-Flores M. Cáncer pulmonar: Distribución de metástasis de acuerdo al tipo histológico. Estudio de autopsias. Rev Inst Nal Enf Resp Mex 2002;15:84-89.

  6. Alva-López LF, Corcho-Verdugo A, García-Sancho C, Salazar-Flores M, Rebora-Togno, Franco-Marina F, et al. Epidemiología del cáncer pulmonar en México; hallazgos por imagen. Rev Inst Nal Enf Resp Mex 2003;16:197-204.

  7. Green LS, Fortoul TI, Ponciano G, Robles C, Rivero O. Bronchogenic cancer in patients under 40 years old. The experience of a Latin American country. Chest 1993;104:1477-1481.

  8. Hirsch FR, Corrin B, Colby TV. Clinical features and staging. En: eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC, 10a edición. Lyon: LARC Press; 2004. pp 16-20.

  9. Dirección General de Información en Salud. Secretaría de Salud, México. Estadísticas de Mortalidad en México: Muertes registradas en el año 2003. Salud Publica Mex 2005;47:171-187.

  10. Ruiz-Godoy L, Rizo-Rios P, Sánchez-Cervantes F, Osornio-Vargas A, García-Cuéllar C, Meneses-García A. Mortality due to lung cancer in Mexico. Lung Cancer 2007;58:184-190.

  11. Tovar-Guzmán VJ, López-Antuñano FJ, Ramírez-Salgado N. Tendencias recientes de la mortalidad por cáncer pulmonar en México, 1980-2000. Rev Panam Salud Publica 2005;17:254-262.

  12. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006;354:333-342.

  13. Yang P, Allen MA, Aubry MC, Wampffler JA, Marks RS, Edell JA, et al. Clinical features of 5,628 primary lung cancer patients. Experience at Mayo Clinic from 1997 to 2003. Chest 2005;128:452-462.

  14. Alonso-Fernández M, García-Clemente M, Escudero-Bueno C. Characteristics of lung cancer in a region in Northern Spain. Arch Bronconeumol 2005;41:478-483.

  15. Santos-Martínez MJ, Curull V, Blanco ML, Facia F, Mojal S, Vila J, et al. Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and historical series. Arch Bronconeumol 2005;41:307-12.

  16. Mäkitaro R, Pääkko P, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: history and histological types in a general population in northern Finland. Eur Respir J 1999;13:436-440.

  17. Salomaa ER, Sällinen S, o Heikkanen H, Liipo K. Delays in the diagnosis and treatment of lung cancer. Chest 2005;128:2282-2288.

  18. Radzikowska E, Glaz P, Roszkowsky K. Lung cancer in women: age, smoking, histology, performance, status, stage, initial treatment and survival. Populationbased study of 20561 cases. Annals of Oncology 2002;13:1087-1093.

  19. Karlikaya C, Cakir-Edis E. Lung cancer histopathology in the Thrace region of Turkey and comparison with national data. Turbek Toraks 2005;53:132-138.

  20. Villalba-Caloca J, Martínez-Heredero R. Frecuencia del carcinoma broncopulmonar en pacientes fumadores y no fumadores diagnosticados en el Instituto Nacional de Enfermedades Respiratorias en el año 2001. Rev Inst Nal Enf Resp Mex 2004;17:27-34.

  21. Medina-Morales F, Echengoyen-Carmona R, Medina-Zarco LE, Galicia- Tapia J. Características del cáncer pulmonar en un hospital de tercer nivel. Rev Neum Cir Torax 2002;61:27-30.

  22. Taoli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-870.

  23. Kuan-Yu C, Chia-Hsuin C, Chong-Jen Y, Sow-Song K, Pan-Chir Y. Distribution according to histologic type and outcome by gender and age Group in taiwanese patients with lung carcinoma, Cancer 2005;103:2566–2575.

  24. González JM, de Castro FJ, Barrueco M, Cordovilla R, Fernández JL, Gómez FP, et al. Demoras diagnósticas en el cáncer de pulmón. Arch Bronconeumol 2003;39:437-441.

  25. Soler T, Isamitt D, Carrasco O. Rendimiento de la biopsia, cepillado y lavado bronquial por fibrobroncoscopia en el diagnóstico de cáncer pulmonar con lesiones visibles endoscópicamente. Rev Med Chile 2004;132:1198-1203




2020     |     www.medigraphic.com